Clinical Trial Update: MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a MUC1 therapeutic tumor vaccine in adults with solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• MUC1 therapeutic tumor vaccine

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Solid Tumor, Adult | Phase 2 | Status: UNKNOWN